INSM and VRTX Related Headlines
Go Back- Truist Securitas's Biotechnology Earnings Preview: 'INSM, BBIO, NBIX Most Levered to the Print'
- JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
- JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
- 4Q25/2026 Biotech Earnings Preview: RBC
